Robotic Lateral Pelvic Lymph Node Dissection in Rectal Cancer: A Feasibility Study from a European Centre

Tou Pin Chang1, Oroog Ali2, Kostas Tsimogiannis3

  • 1Epsom and St. Helier University Hospitals NHS Trust, Carshalton SM5 1AA, UK.

PubMed
Summary

Robotic lateral pelvic lymph node dissection (LPLND) is safe and feasible for rectal cancer patients in the Western hemisphere. This robotic approach shows good short-term outcomes, with transferable ergonomic benefits from standard TME protocols.

Related Concept Videos